ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Stomach Cancer
Colorectal Cancer
Esophageal Cancer
Prostatic Cancer

Adenocarcinoma trials near Montréal, QC, CAN:

Locations recently updated

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) (TroFuse-015)

(TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumote...

Enrolling
Gastroesophageal Cancer
Drug: Rescue medication
Drug: Supportive care measures

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Montréal, Quebec, Canada and 161 other locations

This study is being done to answer the following question:Can the chance of gastroesophageal cancer growing or spreading be lowered by adding a drug...

Enrolling
Gastroesophageal Adenocarcinoma
Drug: Zanidatamab
Drug: Paclitaxel

Phase 2

Canadian Cancer Trials Group

Montreal, Quebec, Canada and 15 other locations

first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Active, not recruiting
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Domvanalimab
Drug: Zimberelimab

Phase 3

Arcus Biosciences
Arcus Biosciences

Montreal, Canada and 203 other locations

after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...

Enrolling
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Rilvegostomig

Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 214 other locations

and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: AZD0901
Drug: Docetaxel

Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 182 other locations

mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (PDAC) who have not received prior systemic anti-cancer tre...

Enrolling
Adenocarcinoma, Pancreatic Ductal
Drug: mFOLFIRINOX
Drug: Autogene cevumeran

Phase 2

Genentech
Genentech

Montreal, Quebec, Canada and 67 other locations

Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesop...

Active, not recruiting
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: folinic acid
Drug: zolbetuximab

Phase 3

Astellas
Astellas

Montreal, Quebec, Canada and 219 other locations

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer age...

Enrolling
Lung Adenocarcinoma
Ovarian Cancer
Drug: Bevacizumab
Drug: AZD5335

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 55 other locations

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer.

Enrolling
Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
Alpha Tau Medical

Montréal, Quebec, Canada and 1 other location

untreated adults with gastric and gastroesophageal junction (GEJ) adenocarcinoma.The primary study hypotheses are that:* Neoadjuvant and adj...

Active, not recruiting
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: Cisplatin
Drug: Capecitabine

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Montreal, Quebec, Canada and 170 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems